Hidradenitis suppurativa
Though we enjoyed the review on hidradenitis suppurativa (HS) by Dr Mortimer and Mr Lunniss (August 2000, JRSM, pp. 420±22) we feel that their brief comments on androgen dependence and antiandrogen therapy need quali®cation. They cite evidence from the study by Barth and Kealey 1 , who investigated androgen converting enzyme activity in the apocrine glands of HS patients and found no increase in activity. These data are interpreted as re¯ecting lack of apocrine sensitivity to androgens, but this inference is misleading, since the data relate to the quantity of active metabolite (dihydrotestosterone) and not the androgen response at receptor level. In this regard it is noteworthy that ®nasteride, a type 2 5a-reductase inhibitor of testosterone to dihydrotestosterone conversion, gave apparent bene®t in 4 recalcitrant cases of HS 2 .
In higher primates apocrine glands are androgen dependent, as manifest by the role of these glands in cutaneous chemical communication during mating activities. This important body odour is formed at the piloapocrine sites (mainly axillae, inguinal region and perianal and natal cleft areas) by the bacterial decomposition of apocrine secretions. In humans a similar, albeit more re®ned, process of apocrine maturation and function occurs with the onset of body odour at adolescence and not before, substantiating the basis of androgen dependency. Although HS has occurred in a girl of 7 years, this was the presenting feature of premature adrenarche 3 .
Observational studies have shown that HS¯ares premenstrually but tends not to during anovulatory cycles 4 . Affected women also have a high prevalence of acne and hirsutism which are known androgenic conditions. Initial studies showed that HS patients had biochemical hyperandrogenism 5 but this was refuted by a comparison with controls matched for age, weight and hirsutes 6 . However, androgen pro®les can be normal in known androgenic conditions such as acne vulgaris, hirsutism and androgenic alopecia. The mode of action is therefore considered to be at the receptor level, as supported by the association of dissecting folliculitis, acne conglobata and HSÐthe`follicular occlusion triad'. Ebling and Randall from a zoological background (with Sawers) suggested antiandrogen therapy on the basis of comparative endocrinology. A pilot study con®rmed the hypothesis by demonstrating bene®ts from antiandrogen therapy in HS 7 .
Despite the disparate views on the aetiological signi®cance of apocrine glands in HS and androgen dependence, antiandrogen therapy is clinically helpful in HS patients 7, 8 . We feel that female patients without contraindications should be offered an antiandrogen preparation such as Dianette as an adjunct to other medical and surgical treatment. The ef®cacy of short-course, highdose cyproterone acetate should not be underestimated 7 . Even brief remission in a refractory case may be very advantageous. Hospitalists for the NHS I write in response to the article by Dr Mainous and colleagues (October 2000 JRSM, pp. 504±506). As a geriatrician I regard myself as a general physician in the care of the elderly. I also work in an acute integrated care system and do on-call duties with post-take ward rounds. Over a period of time, I have realized that I need to specialize in a few diseasesÐnamely, gait and movement disorders including Parkinson's disease, heart failure, stroke, chronic obstructive pulmonary disease, detection of cancer in the elderly, urinary and faecal incontinence, falls and emergency treatment of acute haemorrhages. I do feel that a system including an organ specialist, a generalist and a general practitioner caring for the patient would be the ideal in a world constrained by time, ®nance and manpower. A hospital full of single organ specialists and a community full of GPs, with no`intermediate care physicians' in situ, would be a nightmare.
